Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study
Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study
Recruiting · NCT03373968 · Registry updated 2026-01-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne muscular dystrophy, Muscular Disorders, Atrophic, X-linked disease, hereditary disease, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, nervous system disorder, neuromuscular disease | Recruiting | Phase 2 / Phase 3 | 2026-01-21 | NCT03373968 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cromsource | 2 |
| Italfarmaco | 5 |
39 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.